Novo Nordisk's Ozempic has been shown to improve waking distance and quality of life in people with type 2 diabetes (T2D) and peripheral artery disease (PAD), potentially adding yet another indication ...

When Albany lawmakers crafted New York's Raise the Age law in 2017, they didn't define "extraordinary circumstances," a point of contention in Wednesday's New York Court of Appeals case, People v.